Henderson Global Investors

Simba Sleep Limited is a London-based company specializing in the design and manufacture of innovative mattresses and sleep-related products. Founded in 2015, it offers a diverse range of foam mattresses that incorporate a unique combination of conical pocket springs and precision-engineered foam, ensuring optimal comfort and support. In addition to mattresses, Simba Sleep provides a variety of sleep accessories, including pillows, duvets, and bed bases, all crafted with advanced materials to enhance sleep quality. The company emphasizes the importance of sleep and aims to help customers achieve restorative rest. Simba Sleep sells its products through select retail partners, notably John Lewis, and also operates a robust online platform for direct consumer sales.

Simba Sleep Limited is a London-based company specializing in the design and manufacture of innovative mattresses and sleep-related products. Founded in 2015, it offers a diverse range of foam mattresses that incorporate a unique combination of conical pocket springs and precision-engineered foam, ensuring optimal comfort and support. In addition to mattresses, Simba Sleep provides a variety of sleep accessories, including pillows, duvets, and bed bases, all crafted with advanced materials to enhance sleep quality. The company emphasizes the importance of sleep and aims to help customers achieve restorative rest. Simba Sleep sells its products through select retail partners, notably John Lewis, and also operates a robust online platform for direct consumer sales.

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing therapies for chronic respiratory diseases with unmet medical needs. Its lead candidate, ensifentrine, is an inhaled dual inhibitor of phosphodiesterases 3 and 4 that provides bronchodilation and anti-inflammatory effects in a single molecule. Development programs include formulations of ensifentrine for chronic obstructive pulmonary disease, with options such as nebulized administration, a dry powder inhaler, and a pressurized metered-dose inhaler. Verona Pharma is also pursuing development of ensifentrine for cystic fibrosis and asthma. The company was founded in 2005 and is headquartered in London, United Kingdom.

Gartmore Investment Limited is a privately owned investment management firm based in London, United Kingdom. Established in 1969, the company specializes in managing hedge funds and offers a diverse array of investment products and services designed to cater to the needs of both retail and institutional clients. Gartmore operates as a subsidiary of Henderson Global Investors Limited and has a reputation for being a respected independent fund manager, focusing solely on asset management. The firm is dedicated to providing tailored investment solutions to meet the varying demands of its clientele.

New Star Asset Management is an investment management holding company. The company through its subsidiaries provides services in areas including UK investment funds, investment trusts, offshore funds/SICAVs, alternative investments, and Specialist institutional funds.

Sharda Cropchem is an Indian agrochemical company that distributes formulations and generic active ingredients such as insecticides, fungicides, and veterinary drugs. They also supply conveyor belts, V-belts, organic and inorganic chemicals for various industrial applications.

Alaunos Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies for solid tumors. Utilizing its proprietary gene expression technology, the company aims to precisely modulate gene expression at cancer sites, improving therapeutic outcomes. Currently, it is evaluating its lead candidate, an interleukin-12 therapy for breast cancer and advanced melanoma, in Phase 2 clinical studies.

Alaunos Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies for solid tumors. Utilizing its proprietary gene expression technology, the company aims to precisely modulate gene expression at cancer sites, improving therapeutic outcomes. Currently, it is evaluating its lead candidate, an interleukin-12 therapy for breast cancer and advanced melanoma, in Phase 2 clinical studies.

Homann Feinkost GmbH, established in 1876 and headquartered in Dissen, Germany, specializes in the production of chilled food products. Its portfolio includes a variety of items such as bread and dip, mayonnaise, salad dressing, and prepared salads and seafood buffet options. As of April 2015, the company operates under Gastronomia y Negocios S.A., serving both retail and catering markets with its diverse range of products designed for various occasions like meals at home, office snacks, or social gatherings.

Italian fitness and wellness chain